Indication
Prevention of venous thromboembolic events
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Venous Thromboembolism;Arthroplasty, Replacement
Marketing Authorisation Holder: Accord Healthcare S.L.U.
EMA Authorisation: 26/05/2023
INN: dabigatran etexilate
AI Drug & Interaction Analysis
Free account required
Ask Osler about Dabigatran Etexilate Accord: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.